Zai Lab Ltd.

General Information
Business:

We are an innovative biopharmaceutical company based in Shanghai focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. We believe there exists a significant opportunity to build an organization that not only addresses such unmet needs but leverages underutilized resources in China to foster innovation.

Industry: PHARMACEUTICAL PREPARATIONS
Employees: 50
Founded: 2013
Contact Information
Address 4560 Jinke Road, Bldg. 1, 4F, Pudong, Shanghai, 201210, China
Phone Number +86 21 6163 2588
Web Address http://www.zailaboratory.com
View Prospectus: Zai Lab Ltd.
Financial Information
Market Cap $887.5mil
Revenues $0 mil (last 12 months)
Net Income $-50.1 mil (last 12 months)
IPO Profile
Symbol ZLAB
Exchange NASDAQ
Shares (millions): 8.3
Price range $18.00 - $18.00
Est. $ Volume $150.0 mil
Manager / Joint Managers J.P. Morgan/ Citigroup/ Leerink Partners
CO-Managers -
Expected To Trade: 9/20/2017
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change